Salivary adenoid cystic carcinoma in Denmark 1990–2005: Outcome and independent prognostic factors including the benefit of radiotherapy. Results of the Danish Head and Neck Cancer Group (DAHANCA)

Highlights • A national Danish study presenting 201 patients with adenoid cystic carcinoma. • 10-year disease specific survival was 75%. • 36% experienced recurrence during follow-up (median 7.5 years). • The treatment of choice is surgery with free margins. • Adjuvant radiotherapy should be conside...

Full description

Saved in:
Bibliographic Details
Published inOral oncology Vol. 51; no. 12; pp. 1138 - 1142
Main Authors Bjørndal, Kristine, Krogdahl, Annelise, Therkildsen, Marianne H, Charabi, Birgitte, Kristensen, Claus A, Andersen, Elo, Schytte, Sten, Primdahl, Hanne, Johansen, Jørgen, Pedersen, Henrik B, Andersen, Lisbeth J, Godballe, Christian
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.12.2015
Subjects
Adenoid cystic carcinoma
Adolescent
Adult
Aged
Aged, 80 and over
Carcinoma, Adenoid Cystic - mortality
Carcinoma, Adenoid Cystic - therapy
Child
Denmark - epidemiology
Female
Hematology, Oncology and Palliative Medicine
Humans
Male
Middle Aged
National
Neoplasm Recurrence, Local - mortality
Otolaryngology
Prognosis
Radiotherapy
Radiotherapy, Adjuvant
Salivary Gland Neoplasms - mortality
Salivary Gland Neoplasms - therapy
Survival Analysis
Treatment
Young Adult
Prognosis
Treatment
National
Radiotherapy
Adenoid cystic carcinoma
Online AccessGet full text

Cover

More Information
Summary:Highlights • A national Danish study presenting 201 patients with adenoid cystic carcinoma. • 10-year disease specific survival was 75%. • 36% experienced recurrence during follow-up (median 7.5 years). • The treatment of choice is surgery with free margins. • Adjuvant radiotherapy should be considered in selected patients.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1368-8375
1879-0593
DOI:10.1016/j.oraloncology.2015.10.002